ChEMBL ligand: CHEMBL898 (Diflunisal, Dolobid, Dolobid 500, NSC-756728)
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase in Human [ChEMBL: CHEMBL4105941] [UniProtKB: Q8TDX5] There should be some charts here, you may need to enable JavaScript!
carbonic anhydrase 1/Carbonic anhydrase I in Human [ChEMBL: CHEMBL261] [GtoPdb: 2597] [UniProtKB: P00915] There should be some charts here, you may need to enable JavaScript!
carbonic anhydrase 2/Carbonic anhydrase II in Human [ChEMBL: CHEMBL205] [GtoPdb: 3092] [UniProtKB: P00918] There should be some charts here, you may need to enable JavaScript!
dihydrofolate reductase/Dihydrofolate reductase in Human [ChEMBL: CHEMBL202] [GtoPdb: 2603] [UniProtKB: P00374] There should be some charts here, you may need to enable JavaScript!
Organic anion transporter 1/Solute carrier family 22 member 6 in Human [ChEMBL: CHEMBL1641347] [GtoPdb: 1025] [UniProtKB: Q4U2R8] There should be some charts here, you may need to enable JavaScript!
transthyretin/Transthyretin in Human [ChEMBL: CHEMBL3194] [GtoPdb: 2851] [UniProtKB: P02766] There should be some charts here, you may need to enable JavaScript!

DB	Assay description	Assay Type	Standard value	Standard parameter	Original value	Original units	Original parameter	Reference
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105941] [UniProtKB: Q8TDX5]
ChEMBL	Competitive inhibition of human ACMSD using ACMS substrate by spectrometry	B	5.59	pKi	2560	nM	Ki	J Med Chem (2021) 64: 797-811 [PMID:33369426]
ChEMBL	Inhibition of human ACMSD using ACMS substrate by spectrometry	B	4.87	pIC50	13500	nM	IC50	J Med Chem (2021) 64: 797-811 [PMID:33369426]
carbonic anhydrase 1/Carbonic anhydrase I in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL261] [GtoPdb: 2597] [UniProtKB: P00915]
ChEMBL	Inhibition of human carbonic anhydrase 1 esterase activity by noncompetitive Lineweaver-Burke plot	B	5.07	pKi	8450	nM	Ki	Bioorg Med Chem (2008) 16: 9101-9105 [PMID:18819808]
ChEMBL	Inhibition of human carbonic anhydrase 1 esterase activity by spectrophotometry	B	5.47	pIC50	3380	nM	IC50	Bioorg Med Chem (2008) 16: 9101-9105 [PMID:18819808]
carbonic anhydrase 2/Carbonic anhydrase II in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL205] [GtoPdb: 3092] [UniProtKB: P00918]
ChEMBL	Inhibition of human carbonic anhydrase 2 esterase activity by non-competitive Lineweaver-Burke plot	B	5.03	pKi	9370	nM	Ki	Bioorg Med Chem (2008) 16: 9101-9105 [PMID:18819808]
ChEMBL	Inhibition of human carbonic anhydrase 2 esterase activity by spectrophotometry	B	5.57	pIC50	2700	nM	IC50	Bioorg Med Chem (2008) 16: 9101-9105 [PMID:18819808]
dihydrofolate reductase/Dihydrofolate reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL202] [GtoPdb: 2603] [UniProtKB: P00374]
ChEMBL	Inhibition of human DHFR in presence of DHF and NADPH by UV-vis spectrometry by Lineweaver-Burk plot analysis	B	4.47	pKi	34000	nM	Ki	J Med Chem (2020) 63: 8314-8324 [PMID:32658475]
GtoPdb	-	-	4.47	pKi	34000	nM	Ki	Journal of Medicinal Chemistry (2020) :
Organic anion transporter 1/Solute carrier family 22 member 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1641347] [GtoPdb: 1025] [UniProtKB: Q4U2R8]
ChEMBL	TP_TRANSPORTER: inhibition of Adefovir uptake in OAT1-expressing CHO cells	F	6.07	pIC50	850	nM	IC50	J Pharmacol Exp Ther (2000) 295: 10-15 [PMID:10991954]
transthyretin/Transthyretin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3194] [GtoPdb: 2851] [UniProtKB: P02766]
ChEMBL	Stabilization of TTR V30M mutant (unknown origin) assessed as inhibition of protein-mediated amyloid fibril formation	B	5.25	pKd	5600	nM	Kd	J Med Chem (2020) 63: 14228-14242 [PMID:32914975]
ChEMBL	Stabilization of wild type human transthyretin expressed in Escherichia coli BL21(DE3) Star assessed as dissociation constant for TTR-amyloid beta (12 to 28) complex formation at 200 uM at 25 degC pre-incubated with transthyretin before amyloid beta (12 to 28) addition by ITC assay (Rvb = 3 +/- 0.2 microM)	B	5.57	pKd	2700	nM	Kd	J Med Chem (2020) 63: 3205-3214 [PMID:32124607]
ChEMBL	Binding affinity to TTR V30M mutant (unknown origin) by isothermal titration calorimetry	B	5.89	pKd	1300	nM	Kd	J Med Chem (2021) 64: 14344-14357 [PMID:34547896]
ChEMBL	Binding affinity to TTR (unknown origin) by isothermal titration calorimetric analysis	B	6.24	pKd	580	nM	Kd	J Med Chem (2015) 58: 6507-6515 [PMID:26214366]
ChEMBL	Binding affinity to transthyretin (unknown origin) by ITC method	B	6.39	pKd	407	nM	Kd	J Med Chem (2018) 61: 7862-7876 [PMID:30133284]
ChEMBL	Binding affinity to wild type TTR (unknown origin) expressed in Escherichia coli BL21/DE3 by Circular dichroism spectroscopy	B	7.12	pKd	75	nM	Kd	J Med Chem (2020) 63: 14228-14242 [PMID:32914975]
ChEMBL	Binding affinity to TTR in human plasma assessed as protein stabilization preincubated for 1 hr followed by urea-mediated denaturation by Western blot analysis	B	4.6	pIC50	25000	nM	IC50	J Med Chem (2015) 58: 6507-6515 [PMID:26214366]
ChEMBL	Inhibition of ANS binding to TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as BC50 for ANS binding to TTR at 5 uM in presence of 150 mM Na+ by fluorescence-based assay (Rvb = 3 uM)	B	4.92	pIC50	12000	nM	IC50	J Med Chem (2019) 62: 2076-2082 [PMID:30688456]
ChEMBL	Inhibition of acid-mediated aggregation of TTR V30M mutant (unknown origin) expressed in Escherichia coli pretreated for 30 mins at pH 7 followed by protein dilution in acetate buffer and further incubated for 96 hrs at pH 4.6 by thioflavin-T fluorescence assay	B	5.18	pIC50	6600	nM	IC50	Bioorg Med Chem (2021) 44: 116292-116292 [PMID:34225167]
ChEMBL	Inhibition of transthyretin V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of sodium acetate-mediated aggregation preincubated for 30 mins followed by sodium acetate addition measured after 96 hrs by thioflavin T assay	B	5.2	pIC50	6300	nM	IC50	J Med Chem (2014) 57: 1090-1096 [PMID:24422526]
ChEMBL	Stabilization of TTR V3OM mutant (unknown origin) assessed as acid-mediated protein aggregation inhibition ratio incubated for 1 week by absorbance method	B	5.46	pIC50	3500	nM	IC50	J Med Chem (2021) 64: 14344-14357 [PMID:34547896]
ChEMBL	Inhibition of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of amyloid fibril formation by fluorescence assay	B	5.25	pEC50	5600	nM	EC50	J Med Chem (2014) 57: 8928-8935 [PMID:25314129]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]